ProstaLund has previously signed distribution agreements for the UK, Italy, Poland and Spain in Europe for its Stand-Alone products, Schelin Catheter® and CoreFlow® Soft Stent.

- “Switzerland is not, and will not be, a large market for us, but it is interesting from many other aspects. One aspect is that it is a multi-language country. That's also one of the reasons we didn't sign an exclusive agreement with only one party, but a couple. It will also mean that we will get both German-speaking and French-speaking reference clinics in the near future, which enables continued expansion in the surrounding countries. The fact that Switzerland is not part of the EU and has its own regulatory rules means that we have only chosen at this stage to go in with Schelin Catheter®. Switzerland is also a country where high quality products and services are appreciated and I can very well imagine that it could become a country for our treatment method when we later roll out CoreTherm® Eagle in Europe," says CEO Johan Wennerholm in a comment.